Cita APA

Martínez-González, L., Gonzalo-Consuegra, C., Gómez-Almería, M., Porras, G., De Lago, E., Martín-Requero, Á., & Martínez Gil, A. (2021). Tideglusib, a non-ATP competitive inhibitor of GSK-3β as a drug candidate for the treatment of amyotrophic lateral sclerosis.

Citación estilo Chicago

Martínez-González, Loreto, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Gracia Porras, E. De Lago, Ángeles Martín-Requero, y Ana Martínez Gil. Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β As a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. 2021.

Cita MLA

Martínez-González, Loreto, et al. Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β As a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis. 2021.